Study to Assess Adverse Events and How Oral ABBV-990 Moves Through the Body of Adult Healthy Participants
Clinical trial NCT05475821 · TERMINATED
Trial details
- NCT number
- NCT05475821
- Sponsor
- AbbVie
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-25
- Primary completion
- 2022-09-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.